-
Biopharma ramps up lobbying spend as drug pricing legislation nears — Roche culls two COVID-19 hopefuls amid Q1 clear-out — FDA offers scathing review of Emergent plantSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Party is over
Discussion in 'Dermira' started by anonymous, Oct 1, 2018 at 5:19 AM.
Tags:
Add Tags
Page 2 of 4
Page 2 of 4